vipulkumar mohanlal parmar

Dr. vipulkumar mohanlal parmar

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2020 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
LTLinda D. Thomas
Linda D. Thomas
SBSepalika Bandara
Sepalika Bandara
VPvipulkumar mohanlal parmar
vipulkumar mohanlal parmar
RSRamkumar Srinivasagan
Ramkumar Srinivasagan
NKNimesh Khadka
Nimesh Khadka
Johannes von LintigJohannes von Lintig
Johannes von Lintig
The enzyme β-carotene-oxygenase 2 (BCO2) converts carotenoids into more polar metabolites. Studies in mammals, fish and birds revealed that BCO2 controls carotenoid homeostasis and is involved in the pathway for vitamin A production. However, it is controversial whether BCO2 function is conserved in humans, owing to a four amino acid long insertion caused by a splice acceptor site polymorphism. We here show that human BCO2 splice variants, BCO2a and BCO2b, are expressed as pre-proteins with mitochondrial targeting sequence (MTS). The MTS of BCO2a directed a green fluorescent reporter protein to the mitochondria when expressed in ARPE-19 cells. Removal of the MTS increased solubility of BCO2a when expressed in E. coli and rendered the recombinant protein enzymatically active. The expression of the enzymatically active recombinant human BCO2a was further improved by codon optimization and its fusion with maltose-binding protein. Introduction of the four amino acid insertion into mouse Bco2 did not impede the chimeric enzyme’s catalytic proficiency. We further showed that the chimeric BCO2 displayed broad substrate specificity and converted carotenoids into two ionones and a central C14-apocarotendial by oxidative cleavage reactions at C9,C10 and C9’,C10’. Thus, our study demonstrate that human BCO2 is a catalytically competent enzyme. Consequently, information on BCO2 becomes broadly applicable in human biology with important implications for the physiology of the eyes and other tissues.

8 July 2022 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PYPei-Li Yao
Pei-Li Yao
VPvipulkumar mohanlal parmar
vipulkumar mohanlal parmar
MCMayur Choudhary
Mayur Choudhary
GMGoldis Malek
Goldis Malek
Phenotypic variations in the retinal pigment epithelial (RPE) layer are often a predecessor and driver of ocular degenerative diseases, such as age-related macular degeneration (AMD), the leading cause of vision loss in the elderly. We previously identified the orphan nuclear receptor-related 1 (NURR1), from a nuclear receptor atlas of human RPE cells, as a candidate transcription factor potentially involved in AMD development and progression. In the present study we characterized the expression of NURR1 as a function of age in RPE cells harvested from human donor eyes and in donor tissue from AMD patients. Mechanistically, we found an age-dependent shift in NURR1 dimerization from NURR1-RXRα heterodimers toward NURR1-NURR1 homodimers in primary human RPE cells. Additionally, overexpression and activation of NURR1 attenuated TNF-α–induced epithelial-to-mesenchymal transition (EMT) and migration, and modulated EMT-associated gene and protein expression in human RPE cells independent of age. In vivo, oral administration of IP7e, a potent NURR1 activator, ameliorated EMT in an experimental model of wet AMD and improved retinal function in a mouse model that presents with dry AMD features, impacting AMD phenotype, structure, and function of RPE cells, inhibiting accumulation of immune cells, and diminishing lipid accumulation. These results provide insight into the mechanisms of action of NURR1 in the aging eye, and demonstrate that the relative expression levels and activity of NURR1 is critical for both physiological and pathological functions of human RPE cells through RXRα-dependent regulation, and that targeting NURR1 may have therapeutic potential for AMD by modulating EMT, inflammation, and lipid homeostasis.

2 August 2022 in Cells
Verified
Journal Article
Open access
PDF file
JPJeremy Peavey
Jeremy Peavey
VPvipulkumar mohanlal parmar
vipulkumar mohanlal parmar
GMGoldis Malek
Goldis Malek
The choroid is a vulnerable tissue site in the eye, impacted in several blinding diseases including age related macular degeneration (AMD), which is the leading cause of central vision loss in the aging population. Choroidal thinning and choriocapillary dropout are features of the early form of AMD, and endothelial dysfunction and vascular changes are primary characteristics of the neovascular clinical sub-type of AMD. Given the importance, the choroidal endothelium and outer vasculature play in supporting visual function, a better understanding of baseline choroidal signaling pathways engaged in tissue and cellular homeostasis is needed. Nuclear receptors are a large family of transcription factors responsible for maintaining various cellular processes during development, aging and disease. Herein we developed a comprehensive nuclear receptor atlas of human choroidal endothelial cells and freshly isolated choroidal tissue by examining the expression levels of all members of this transcription family using quantitative real time PCR. Given the close relationship between the choroid and retinal pigment epithelium (RPE), this data was cross-referenced with the expression profile of nuclear receptors in human RPE cells, to discover potential overlap versus cell-specific nuclear receptor expression. Finally, to identify candidate receptors that may participate in the pathobiology of AMD, we cataloged nuclear receptor expression in a murine model of wet AMD, from which we discovered a subset of nuclear receptors differentially regulated following neovascularization. Overall, these databases serve as useful resources establishing the influence of nuclear receptor signaling pathways on the outer vascular tissue of the eye, while providing a list of receptors, for more focused investigations in the future, to determine their suitability as potential therapeutic targets for diseases, in which the choroid is affected.

10 June 2022 in Antioxidants
Verified
Journal Article
Open access
PDF file
RSRamkumar Srinivasagan
Ramkumar Srinivasagan
VPvipulkumar mohanlal parmar
vipulkumar mohanlal parmar
JMJean Moon
Jean Moon
CLChieh Lee
Chieh Lee
PTPatricia Taylor
Patricia Taylor
Johannes von LintigJohannes von Lintig
Johannes von Lintig
Emerging evidence indicates that diabetes disturbs photoreceptor function and vitamin A homeostasis. However, the biochemical basis of this phenotype is not well established. Here, we compared the effects of streptozotocin-induced diabetes in wild-type (WT) mice and Stra6-/- mice, a mouse model for ocular vitamin A deficiency. After 8 weeks, diabetes increased serum retinyl esters in mice of both genotypes. The eyes of diabetic WT mice displayed increased superoxide levels but no changes in retinoid concentrations. Diabetic Stra6-/- mice showed increased ocular retinoid concentrations, but superoxide levels remained unchanged. After 30 weeks, significant alterations in liver and fat retinoid concentrations were observed in diabetic mice. Diabetic WT mice exhibited a decreased expression of visual cycle proteins and a thinning of the photoreceptor layer. Stra6-/- mice displayed significantly lower ocular retinoid concentration than WT mice. An altered retinal morphology and a reduced expression of photoreceptor marker genes paralleled these biochemical changes and were more pronounced in the diabetic animals. Taken together, we observed that diabetes altered vitamin A homeostasis in several organ systems and aggravated photoreceptor pathologies in the vitamin-deficient mouse eyes.


12 August 2025 in Journal of Biological Chemistry
Verified
Journal Article
Open access
AWAlexander M. Warwick
Alexander M. Warwick
LYLin Yu
Lin Yu
MKMikael Klingeborn
Mikael Klingeborn
ATAmanda M. Travis
Amanda M. Travis
VPvipulkumar mohanlal parmar
vipulkumar mohanlal parmar
SGSidney M. Gospe
Sidney M. Gospe
Mutations in the mitochondrial respiratory complex I accessory subunit NADH:ubiquinone oxidoreductase subunit S4 (ndufs4) can cause the mitochondrial disease Leigh syndrome, which may be associated with vision loss. We previously demonstrated that mice with global deletion of ndufs4 exhibited impaired in vivo photoreceptor light responses prior to the early death of the mice around postnatal day 50. However, ex vivo electrophysiology recordings performed on retinas from ndufs4-/- mice were normal, suggesting that the in vivo phenotype may reflect altered homeostasis of the extracellular environment of photoreceptors rather than their intrinsic metabolic dysfunction. To test this hypothesis, we have generated mouse strains with cell-specific deletions of ndufs4 from rod photoreceptors and from the retinal pigment epithelium (RPE), a key supporting cell to photoreceptors. We now demonstrate that despite efficient depletion of NDUFS4 protein and consequent reduction of complex I activity in rods, scotopic electroretinography (ERG) responses are essentially normal and rod survival is not impacted by rod-specific ndufs4 deletion. Interestingly, while RPE-specific deletion of ndufs4 depletes NDUFS4 protein and reduces complex I activity in RPE, a ∼15% reduction in ERG amplitudes is observed, much less than the 50% reduction previously reported in global ndufs4-/- mice. This suggests that a more complex metabolic relationship exists between photoreceptors, RPE, and other cells of the retina to establish the homeostatic physiological conditions necessary for normal light signaling.